Although this pattern allows to provide an easy read-out for therapeutic screening, the study of pathophysiological mechanisms underlying consequences of DUX4 muscle expression requires a more scattered distribution pattern of the transgene, closer to the one observed in FSHD muscles. This evidence concerns the gene DUX4 and facioscapulohumeral muscular dystrophy.